Tumor Lysis Syndrome Laboratory Evaluation vs Rhabdomyolysis
Laboratory tumor lysis syndrome (TLS) is differentiated from rhabdomyolysis by the pattern of metabolic derangements in nucleic-acid breakdown (hyperuricemia, hyperphosphatemia, hypocalcemia, with hyperkalemia) rather than by a marked muscle-injury marker elevation (creatine kinase [CK]) with myoglobinuria. [1][2]
Tumor Lysis Syndrome Key Blood Tests (Cairo-Bishop Laboratory TLS)
Laboratory TLS is supported by serial blood testing demonstrating ≥2 abnormal parameters from the following cluster (with a treatment-related time window). [1][2]
- Serum uric acid (hyperuricemia). [1][2]
- Serum potassium (hyperkalemia). [1][2]
- Serum phosphate (hyperphosphatemia). [1][2]
- Serum calcium (hypocalcemia). [1][2]
Tumor Lysis Syndrome Practical Lab Panel Components
A commonly used TLS workup includes assessments that capture the TLS laboratory cluster and evolving kidney injury.
- Electrolytes: potassium and phosphate. [1][2]
- Calcium. [1][2]
- Uric acid. [1][2]
- Renal function: creatinine and blood urea nitrogen (BUN) as supportive markers of TLS-associated acute kidney injury. [1][2]
Rhabdomyolysis Key Blood Tests
Rhabdomyolysis is differentiated by direct evidence of skeletal muscle necrosis.
- Serum creatine kinase (CK) elevation, typically defined as >5× the upper limit of normal (or >1000 IU/L in many diagnostic summaries). [3][4]
- Serum potassium and creatinine as common complication markers in rhabdomyolysis-associated acute kidney injury and electrolyte derangements. [4][5]
- Serum AST and LDH as commonly elevated muscle-injury biomarkers (supportive rather than specific). [4][5]
Rhabdomyolysis Urine Testing to Confirm Muscle Injury (Not a TLS Signature)
Although the question requests blood tests, rhabdomyolysis confirmation is usually strengthened by urine testing that detects myoglobin.
- Urinalysis showing myoglobinuria: dipstick heme-positive with few red blood cells on microscopy. [6][7]
High-Value Laboratory Pattern Differences
The main laboratory pattern differences used to separate TLS from rhabdomyolysis are summarized below.
- TLS favors hyperuricemia plus hyperphosphatemia plus hypocalcemia, often accompanied by hyperkalemia. [1][2]
- Rhabdomyolysis favors marked CK elevation plus myoglobinuria, with electrolyte abnormalities arising secondarily. [3][6]
Timing and Treatment-Context Clues That Affect Laboratory Interpretation
Laboratory TLS criteria incorporate a temporal relationship to antineoplastic therapy, which supports TLS over rhabdomyolysis when metabolic derangements appear in that window. [1][2]
- Laboratory TLS is defined using Cairo-Bishop timing relative to initiation of chemotherapy (laboratory criteria capture abnormalities before and after treatment start). [1][2]
Suggested Blood Tests for Differential Diagnosis in Practice
A differential-oriented blood test set can be structured as follows.
- If TLS is suspected: serum uric acid, potassium, phosphate, calcium, and creatinine. [1][2]
- If rhabdomyolysis is suspected: serum CK plus creatinine and potassium, with AST and LDH as supportive markers. [4][5]
Tumor Lysis Syndrome Blood-Test Thresholds (Adults) Used in Common Criteria
Adult laboratory TLS thresholds in Cairo-Bishop-derived summaries include absolute values for each analyte used to define clinically significant abnormalities. [1][2]
- Uric acid: ≥8 mg/dL. [1][2]
- Potassium: ≥6.0 mEq/L (or mmol/L in some unit conventions). [1][2]
- Phosphate: ≥4.5 mg/dL. [1][2]
- Calcium: ≤7 mg/dL. [1][2]
Rhabdomyolysis CK Threshold Used in Diagnostic Summaries
Rhabdomyolysis is commonly diagnosed using a CK magnitude threshold that supports skeletal muscle necrosis. [3][4]
- CK: typically >5× the upper limit of normal (often operationalized as >1000 IU/L in diagnostic summaries). [3][4]
Common Differentiation Pitfall: Shared Electrolyte Abnormalities
Both conditions can produce hyperkalemia and can produce acute kidney injury with rising creatinine, so electrolyte testing alone does not differentiate TLS from rhabdomyolysis. [1][4]
- TLS is identified by the nucleic-acid breakdown triad pattern involving uric acid and phosphate with hypocalcemia. [1][2]
- Rhabdomyolysis is identified by marked CK elevation and myoglobinuria support. [3][6]